selected publications
-
academic article
-
Davalos Salas MMontgomery MKReehorst CNightingale RNg IAnderton HAl-Obaidi SLesmana AScott CIoannidis PKalra HKeerthikumar STogel LRigopoulos AGong SWilliams DSYoganantharaja PBell-Anderson KMathivanan SGibert YHiebert SScott AMWatt MJMariadason JM. Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity.
Nature Communications.
10.
2019
Full text if available -
Burvenich IParakh SLee FGuo NLiu ZGan HKRigopoulos AO'Keefe GGong SGoh YTochon-Danguy HScott FKotsuma MHirotani KSenaldi GScott A. Molecular imaging of T cell co-regulator factor B7-H3 with 89Zr-DS-5573a.
Theranostics.
8:4199-4209.
2018
Full text if available -
Burvenich IJGParakh SLee F-TGuo NLiu ZGan HKRigopoulos AO'Keefe GJGong SJGoh YWTochon-Danguy HScott FEKotsuma MHirotani KSenaldi GScott AM. Molecular imaging of T cell co-regulator factor B7-H3 with Zr-89-DS-5573a.
Theranostics.
8:4199-4209.
2018
Full text if available -
Burvenich IJGLee F-TO'Keefe GJMakris DCao DGong SRigopoulos AAllan LCBrechbiel MWLiu ZRamsland PAScott AM. Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers.
EJNMMI Research.
6:1-13.
2016
Full text if available -
Burvenich IJGLee F-TGuo NGan HKRigopoulos AParslow ACO'Keefe GJGong SJTochon-Danguy HRudd SEDormelly PSKotsuma MOhtsuka TSenaldi GScott AM. In vitro and in vivo evaluation of 89Zr-DS-8273a as a theranostic for anti-death receptor 5 therapy.
Theranostics.
6:2225-2234.
2016
Full text if available -
Lee FTBurvenich IJGGuo NKocovski PTochon-Danguy HAckermann UO'Keefe GJGong SRigopoulos ALiu ZGan HKScott AM. L-Tyrosine Confers Residualizing Properties to a D-Amino Acid-Rich Residualizing Peptide for Radioiodination of Internalizing Antibodies.
Molecular Imaging.
15:1-9.
2016
Full text if available -
Burvenich IJGParakh SGan HKLee F-TGuo NRigopoulos ALee S-TGong SO'Keefe GJTochon-Danguy HKotsuma MHasegawa JSenaldi GScott AM. Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with Zr-89-DS-8895a.
Journal of Nuclear Medicine.
57:974-980.
2016
Full text if available -
Chang JHLim Joon DDavis IDLee STHiew CYEsler SGong SJWada MClouston DO'Sullivan RGoh YPBolton DScott AMKhoo V. Comparison of [<sup>11</sup>C]choline positron emission tomography with T2- and diffusion-weighted magnetic resonance imaging for delineating malignant intraprostatic lesions.
International Journal of Radiation: Oncology - Biology - Physics.
92:438-445.
2015
Full text if available -
Glikmann-Johnston YSaling MMChen JO'Keefe GGong STochon-Danguy HMulligan RReutens DC. Hippocampal 5-HT 1A receptor binding is related to object–location memory in humans.
Brain Structure and Function.
220:559-570.
2015
Full text if available -
Greening DWLee STJi HSimpson RJRigopoulos AMurone CFang CGong SO'Keefe GScott AM. Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways.
Oncotarget.
6:38166-38180.
2015
Full text if available -
Ciprotti MTebbutt NCLee F-TLee S-TGan HKMcKee DCO'Keefe GJGong SJChong GHopkins WChappell BScott FEBrechbiel MWTse ANJansen MMatsumura MKotsuma MWatanabe RVenhaus RBeckman RAGreenberg JScott AM. Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer.
Journal of Clinical Oncology.
33:2609-2616.
2015
Full text if available -
Chang JHLim Joon DLee STHiew CYEsler SGong SJWada MClouston DO'Sullivan RGoh YPTochon-Danguy HChan JGBolton DScott AMKhoo VDavis ID. Diffusion-weighted MRI, 11C-choline PET and 18F- fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.
European Radiology.
24:715-722.
2014
Full text if available -
Chang JHWada MAnderson NJLim Joon DLee STGong SJGunawardana DHSachinidis JO'Keefe GGan HKKhoo VScott AM. Hypoxia-targeted radiotherapy dose painting for head and neck cancer using 18F-FMISO PET: A biological modeling study.
Acta Oncologica.
52:1723-1729.
2013
Full text if available -
Burvenich IJGLee FTCartwright GAO'Keefe GJMakris DCao DGong SChueh ACMariadason JMBrechbiel MWBeckman RAFujiwara KVon Roemeling RScott AM. Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008.
Clinical Cancer Research.
19:5984-5993.
2013
Full text if available -
Chang JHLim Joon DLee STGong SJAnderson NJScott AMDavis IDClouston DBolton DHamilton CSKhoo V. Intensity modulated radiation therapy dose painting for localized prostate cancer using C-choline positron emission tomography scans.
International Journal of Radiation: Oncology - Biology - Physics.
83:e692-e697.
2012
Full text if available -
Ly JVRowe CCVillemagne VLZavala JAMa HSahathevan RO'Keefe GGong SJGunawan RChurilov LSaunder TAckerman UTochon-Danguy HDonnan GA. Subacute ischemic stroke is associated with focal 11C PiB positron emission tomography retention but not with global neocortical aβ deposition.
Stroke.
43:1341-1346.
2012
Full text if available -
Fodero-Tavoletti MTOkamura NFurumoto SMulligan RSConnor ARMcLean CACao DRigopoulos ACartwright GAO'Keefe GGong SAdlard PABarnham KJRowe CCMasters CLKudo YCappai RYanai KVillemagne VL. 18F-THK523: A novel in vivo tau imaging ligand for Alzheimer's disease.
Brain: a journal of neurology.
134:1089-1100.
2011
Full text if available -
Chang JHJoon DLLee STGong SJScott AMDavis IDClouston DBolton DHamilton CSKhoo V. Histopathological correlation of 11C-choline PET scans for target volume definition in radical prostate radiotherapy.
Radiotherapy and Oncology.
99:187-192.
2011
Full text if available -
Villemagne VLOkamura NPejoska SDrago JMulligan RSChételat GAckermann UO'Keefe GJones GGong STochon-Danguy HKung HFMasters CLSkovronsky DMRowe CC. In vivo assessment of vesicular monoamine transporter type 2 in dementia with lewy bodies and alzheimer disease.
Archives of Neurology.
68:905-912.
2011
Full text if available -
Ly JVRowe CCVillemagne VLZavala JAMa HO'Keefe GGong SJGunawan RChurilov LSaunder TAckerman UTochon-Danguy HDonnan GA. Cerebral β-amyloid detected by Pittsburgh compound B positron emission topography predisposes to recombinant tissue plasminogen activator-related hemorrhage.
Annals of Neurology.
68:959-962.
2010
Full text if available -
Ly JVDonnan GAVillemagne VLZavala JAMa HO'Keefe GGong SJGunawan RMSaunder TAckerman UTochon-Danguy HChurilov LPhan TGRowe CC. 11C-PIB binding is increased in patients with cerebral amyloid angiopathy-related hemorrhage.
Neurology.
74:487-493.
2010
Full text if available -
O'Keefe GJSaunder THNg SAckerman UTochon-Danguy HJChan JGGong SDyrks TLindemann SHoll GDinkelborg LVillemagne VRowe CC. Radiation Dosimetry of -Amyloid Tracers 11C-PiB and 18F-BAY94-9172.
Journal of Nuclear Medicine.
50:309-315.
2009
Full text if available -
He JO'Keefe GJGong SJJones GSaunder TScott AMGeso M. A Novel Method for Respiratory Motion Gated With Geometric Sensitivity of the Scanner in 3D PET.
IEEE Transactions on Nuclear Science.
55:2557-2565.
2008
Full text if available -
Fedi MBerkovic SFScheffer IEO'Keefe GMarini CMulligan RGong STochon-Danguy HReutens DC. Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy.
Neurology.
71:795-798.
2008
Full text if available -
Ellis JRVillemagne VLNathan PJMulligan RSGong SJChan JGSachinidis JO’Keefe GJPathmaraj KWesnes KA. Relationship between nicotinic receptors and cognitive function in early Alzheimer’s disease: A 2-[18F]fluoro-A-85380 PET study.
Neurobiology of Learning and Memory.
90:404-412.
2008
Full text if available -
He JO'Keefe GJJones GSaunder TGong SJGeso MScott AM. Evaluation of Geometrical Sensitivity for Respiratory Motion Gating by GATE and NCAT Simulation.
Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings.
2007:4165-4168.
2007
Full text if available -
He JO'Keefe GJones GSaunder TGong SScott AGeso M. SU-FF-I-106: Simulation of Respiratory Motion Gating Using GATE and NCAT.
Medical Physics.
34:2362-2362.
2007
Full text if available -
Rowe CCNg SAckermann UGong SJPike KSavage GCowie TFDickinson KLMaruff PDarby DSmith CWoodward MMerory JTochon-Danguy HO'Keefe GKlunk WEMathis CAPrice JCMasters CLVillemagne VL. Imaging -amyloid burden in aging and dementia.
Neurology.
68:1718-1725.
2007
Full text if available -
Ng SVillemagne VLBerlangieri SLee S-TCherk MGong SJAckermann USaunder TTochon-Danguy HJones GSmith CO'Keefe GMasters CLRowe CC. Visual Assessment Versus Quantitative Assessment of 11C-PIB PET and 18F-FDG PET for Detection of Alzheimer's Disease.
Journal of Nuclear Medicine.
48:547-552.
2007
Full text if available
-
Davalos Salas MMontgomery MKReehorst CNightingale RNg IAnderton HAl-Obaidi SLesmana AScott CIoannidis PKalra HKeerthikumar STogel LRigopoulos AGong SWilliams DSYoganantharaja PBell-Anderson KMathivanan SGibert YHiebert SScott AMWatt MJMariadason JM. Deletion of intestinal Hdac3 remodels the lipidome of enterocytes and protects mice from diet-induced obesity.
Nature Communications.
10.
2019
-
conference paper
-
Gan HCher LInglis PLwin ZLau EAckermann UCoombs NRemen KGuo NLee STGong SPalmer JPathmaraj KO'Keefe GScott FDay BBoyd AThomas PDurrant CScott A. PRELIMINARY FINDINGS OF A PHASE I SAFETY AND BIOIMAGING TRIAL OF KB004 (IFABOTUZUMAB) IN PATIENTS WITH GLIOBLASTOMA.
Neuro-Oncology.
6-6.
2019
-
Burvenich IParakh SLee F-TTGuo NYLiu ZGan HRigopoulos AO'Keefe GJGong SJGoh YWScott FKotsuma MHirotani KSenaldi GScott A. PET/MRI with Zr-89-Df-Bz-NCS-Df-DS-5573a as a theranostic approach.
European Journal of Nuclear Medicine and Molecular Imaging.
S639-S640.
2018
Full text if available -
Burvenich IParakh SBurvenich JGLee F-TGuo NGan HKRigopoulos AO'Keefe GJGong STochon-Danguy HKotsuma MHirotani KSenaldi GScott AM. MOLECULAR IMAGING OF T-CELL CO-REGULATOR FACTOR B7-H3 WITH 89Zr-DS-5573A.
Internal Medicine Journal.
20-20.
2017
-
Scott AMAkhurst TLee FCiprotti MDavis IWeickhardt AGan HKocovski PGuo NMurphy DHicks RLee SO'Keefe GGong SHudson P. Phase I Safety and Biodistribution Study of 124I-PEG-AVP0458 Diabody in Patients with TAG-72 Positive Ovarian and Prostate Cancer.
European Journal of Nuclear Medicine and Molecular Imaging.
S122-S122.
2015
-
Scott AMAkhurst TLee F-TCiprotti MDavis IWeickhardt AGan HKocovski PGuo NMileshkin LWilliams SMurphy DHicks RPathmaraj KLee STO'Keefe GGong SOh MWheatcroft MHudson PJ. Abstract CT238: Phase I safety and biodistribution study of 124I-PEG-AVP0458 diabody in patients with TAG-72 positive ovarian and prostate cancer.
Cancer Research.
2015
Full text if available -
Burvenich ILee FTO'Keefe GJMakris DRamsland PALiu ZAllan LPerani ACao DRigopoulos AGong SGloria BScott AM. OPTIMIZING PHARMACOKINETICS AND TARGETING PROPERTIES OF RECOMBINANT ANTI-LEWIS Y ANTIBODY HU3S193 IN A431 TUMOR-BEARING MICE.
Internal Medicine Journal.
6-6.
2015
-
Scott AMAkhurst TLee F-TCiprotti MDavis IWeickhardt AGan HKocovski PGuo NMileshkin LWilliams SMurphy DHicks RPathmaraj KLee STO'Keefe GJGong STochon-Danguy HPoniger SOh MWheatcroft MHudson PJ. PHASE I SAFETY AND BIODISTRIBUTION STUDY OF 124I-PEG-AVP0458 DIABODY IN PATIENTS WITH TAG-72 POSITIVE OVARIAN AND PROSTATE CANCER.
Internal Medicine Journal.
11-11.
2015
-
Lee FTBurvenich IJGGuo NKocovski PTochon-Danguy HAckermann UO'Keefe GJGong SRigopoulos ALiu ZGan HScott A. L‐tyrosine confers greater residualizing properties to a d‐amino acid rich residualizing peptide for radioiodination of internalizing antibodies.
Internal Medicine Journal.
5-6.
2015
Full text if available -
Lee STGong SJHickson KRigopoulos AAckermann UO'Keefe GJScott AM. ASSESSING METABOLIC AND HYPOXIC CHANGES TO TREATMENT IN COLORECTAL XENOGRAFTS WITH NANOPET/MRI.
Internal Medicine Journal.
30-31.
2014
-
Chang JHJoon DLDavis IDLee STHiew CYEsler SGong SJWada MClouston DO'Sullivan RGoh YPBolton DKhoo VScott AM. C-11-CHOLINE PET IS SUPERIOR TO T2-WEIGHTED MRI FOR LOCALISING MALIGNANT INTRAPROSTATIC LESIONS FOR GUIDING PROSTATE CANCER FOCAL THERAPIES.
Internal Medicine Journal.
13-14.
2014
-
Ciprotti MTebbutt NLee FTLee STMcKee DO'Keefe GGong SChappell BBeckmann RScott A. A PHASE I IMAGING AND PHARMACODYNAMIC TRIAL OF CS-1008 IN PATIENTS WITH METASTATIC COLORECTAL CANCER.
Internal Medicine Journal.
9-9.
2013
-
Ciprotti MTebbutt NCLee FTLee STMcKee DCO'Keefe GJGong SJChong GGan HKHopkins WChappell BScott FEBrechbiel MWTse ANJansen MMatsumura MWatanabe RBeckman RAGreenberg JScott AM. A phase I imaging and pharmacodynamic trial of CS-1008 in patients (pts) with metastatic colorectal cancer (mCRC)..
Journal of Clinical Oncology.
2013
-
O'Keefe GGong SHickson KRigopoulos ACao DFrewin MScott A. PRE-CLINICAL IMAGING DEVELOPMENTS AT THE ACRF CENTRE FOR TRANSLATIONAL CANCER RESEARCH AND IMAGING.
Internal Medicine Journal.
24-24.
2013
-
Jackson JEWada MLee STGan HPoon AGong SGunawardana DJoon DLHamilton CScott A. Pre‐Radiotherapy [18F]‐Fluoromisonidazole PET Is Predictive of Long Term Local Control and Survival in Head and Neck Cancer.
Internal Medicine Journal.
7-7.
2013
Full text if available -
Gong SJAckermann UO'Keefe GJCartwright GRigopoulos ACao DArdipradja KLee FTTochon-Danguy HScott AM. PET Image-derived Biodistribution and Dose Assessment of C-11-AG1478 in BALB/c Mice with A431 EGFR-positive Xenografts.
European Journal of Nuclear Medicine and Molecular Imaging.
S324-S324.
2012
-
Gong SJMong LHickson KYoung KWelch JDesmond SPathmaraj KSachinidis JChan GTochon-Danguy HPaul UO'Keefe GScott AM. A FEASIBILITY STUDY OF USING INSTADOSE PERSONAL DOSIMETERS IN A PET FACILITY.
Internal Medicine Journal.
44-44.
2012
-
Lee STDavis IDGong SJShanker LClouston DBolton DMAngus DWebb DLawrentschuk NWoon TSJoon DLChang JHEsler SO'Sullivan RPathmaraj KTochon-Danguy HO'Keefe GScott AM. C-11-CHOLINE PET SCANNING IS MORE ACCURATE THAN BIOPSY IN ASSESSMENT OF LOCALIZED PROSTATE CANCER PLANNED FOR RADICAL PROSTATECTOMY.
Internal Medicine Journal.
26-26.
2012
-
Chang JHWada MAnderson NJJoon DLLee STGong SJGunawardana DO'Keefe GKhoo VScott AM. HYPOXIA-TARGETED RADIOTHERAPY USING FMISO PET IMPROVES TUMOUR CONTROL IN HEAD AND NECK CANCER.
Internal Medicine Journal.
23-23.
2012
-
Pathmaraj KWelch JGong SJHickson KO'Keefe GChan GScott AM. ONGOING STRATEGIES TO MANAGE RADIATION EXPOSURE TO PET STAFF DURING DOSE DISPENSING, DOSE ADMINISTRATION AND PATIENT POSITIONING.
Internal Medicine Journal.
15-15.
2012
-
Chang JHJoon DLLee STGong SJClouston DDavis IDHamilton CSKhoo VScott AM. TUMOUR DELINEATION FOR PROSTATE CANCER RADIOTHERAPY USING C-11-CHOLINE PET SCANS: AN IMAGING-PATHOLOGY CORRELATION STUDY.
Internal Medicine Journal.
16-16.
2012
-
Davis ILee STClouston DShanker LBolton DEsler STochon-Danguy HO'Keefe GGong SScott A. 11C-Choline PET scanning is more accurate than biopsy in assessment of localized prostate cancer planned for radical prostatectomy.
Journal of Nuclear Medicine.
2012
-
Lee SChang JJoon DLGong SAnderson NDavis IClousten DBolton DHamilton CKhoo VScott A. IMRT DOSE PAINTING FOR LOCALISED PROSTATE CARCINOMA USING C-11-CHOLINE PET SCAN.
Internal Medicine Journal.
12-12.
2011
-
Burvenich IJLee FTO'Keefe GMakris DRamsland PALiu ZAllan LPerani ACartwright GCao DRigopoulos AGong SGloria BMurphy RScott AM. Abstract 5318: Optimizing pharmacokinetics and targeting properties of recombinant anti-Lewis Y antibody hu3S193 in A431 tumor-bearing mice.
Cancer Research.
2011
Full text if available -
Lee FTGong SRamachandran MWalkiewicz MRigopoulos ACao DCartwright GBurvenich IO'Keefe GScott A. IMMUNO-POSITRON EMISSION TOMOGRAPHY (PET) OF LEWIS Y (LEY) EXPRESSING XENOGRAFTS USING 89ZR-LABELLED HUMANISED ANTIBODY HU3S193.
Annals of Oncology.
58-58.
2010
-
Lee SChang JJoon DLGong SO'Keefe GDavis IDHamilton CScott AM. Integration of 11C-Choline PET in Radiotherapy Treatment Planning of Prostate Cancer: Results of a Pilot Study.
European Journal of Nuclear Medicine and Molecular Imaging.
S331-S331.
2010
-
Gong SJLee STO'Keefe GBerlangieri SPathmaraj KTochon-Danguy HDavis IDScott AM. Investigating the Optimum Imaging Time Window for Assessing Prostate Cancer with Positron Emission Tomography Using C-11-Choline.
European Journal of Nuclear Medicine and Molecular Imaging.
S325-S326.
2010
-
Chang JJoon DLLee STGong SClouston DShankar LKhoo VDavis IScott AHamilton C. TUMOUR DELINEATION FOR PROSTATE CANCER RADIOTHERAPY USING 18F-FDG AND 11C-CHOLINE PET SCANS: A PATHOLOGY-IMAGING CORRELATION STUDY.
Radiotherapy and Oncology.
S89-S89.
2010
-
Chang JHLim Joon DAnderson NJDavis ILee STGong SShanker LScott AHamilton CS. The Feasibility of Delivering an IMRT Boost to the 11C-Choline-PET-defined Dominant Intraprostatic Lesion.
International Journal of Radiation: Oncology - Biology - Physics.
S323-S323.
2009
Full text if available -
Jianfeng HeO'Keefe GJAckerly TGong SJGeso M. Respiratory motion correction utilizing geometric sensitivity in 3D PET: A simulation study.
IEEE Nuclear Science Symposium Conference Record.
1220-1224.
2009
Full text if available -
Chang JJoon DLAnderson NLee STGong SKhoo VDavis IScott AHamilton C. SIMULTANEOUS INTEGRATED BOOST TO THE 11 C-CHOLINE-PET-DEFINED DOMINANT INTRAPROSTATIC LESION: A TECHNICAL FEASIBiLITY STUDY.
Radiotherapy and Oncology.
S78-S78.
2009
Full text if available -
O'Keefe GSaunder TGong SPathmaraj KTochon-Danguy HVillemagne VKrause SDyrks TDinkelborg LRowe C. Comparisons of animal-human translated and human 18F-BAY94-9172 amyloid radiation dosimetry.
Journal of Nuclear Medicine.
2009
-
Ackermann UO'Keefe GRigopoulos ACao DGong STochon-Danguy HScott A. IMAGING OF THE EGF RECEPTOR IN A431 TUMOR BEARING MICE USING C-11 AG1478.
Journal of Labelled Compounds and Radiopharmaceuticals.
S382-S382.
2009
-
He JO'Keefe GJJones GSaunder TGong SJGeso MScott AM. Evaluation of geometrical sensitivity for respiratory motion gating by GATE and NCAT simulation.
Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings.
4165-4168.
2007
Full text if available -
Jianfeng HeO'Keefe GJGong SJSaunder TJones GScott AMMoshi Geso. Investigation of respiratory motion gating with geometric sensitivity in Allegro PET.
IEEE Nuclear Science Symposium Conference Record.
4336-4344.
2007
Full text if available -
He JO'Keefe GJJones GSaunder TGong SJGeso MScott AM. The Application of GATE and NCAT to Respiratory Motion Simulation in Allegro PET.
IEEE Nuclear Science Symposium Conference Record.
2589-2593.
2006
Full text if available -
Gong SJO’Keefe GJRykers KMantle CGunawardana DHRolfo AWada MScott AM. PET/CT Rigid-Body Registration in Radiation Treatment Planning Settings: Phantom Validation and Strategy Investigation.
Lecture Notes in Computer Science.
222-229.
2006
Full text if available -
Rowe CCAckermann UGong SPike KENovakovic KESavage GNg SMathis CAMasters CLVillemagne VL. Amyloid imaging in Lewy body dementia with C-11-PIB-PET.
Journal of the Neurological Sciences.
S99-S99.
2005
-
Gong SJO'Keefe GJScott AM. Comparison and Evaluation of PET/CT Image Registration.
Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings.
1599-1603.
2005
Full text if available
-
Gan HCher LInglis PLwin ZLau EAckermann UCoombs NRemen KGuo NLee STGong SPalmer JPathmaraj KO'Keefe GScott FDay BBoyd AThomas PDurrant CScott A. PRELIMINARY FINDINGS OF A PHASE I SAFETY AND BIOIMAGING TRIAL OF KB004 (IFABOTUZUMAB) IN PATIENTS WITH GLIOBLASTOMA.
Neuro-Oncology.
6-6.
2019
-
erratum
-
Greening DWLee STJi HSimpson RJRigopoulos AMurone CFang CGong SO'Keefe GScott AM. Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways.
Oncotarget.
35497-35497.
2016
Full text if available
-
Greening DWLee STJi HSimpson RJRigopoulos AMurone CFang CGong SO'Keefe GScott AM. Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways.
Oncotarget.
35497-35497.
2016
-
abstract
-
Scott ABurvenich ILee FO'Keefe GMakris DCao DGong SRigopoulos AAllan LBrechbiel MLiu ZRamsland P. Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers.
Internal Medicine Journal.
19-19.
2016
-
Gong SLee SDavis IO'Keefe GBolton DClouston DDamianovich DPezaro CAngus DTochon-Danguy HChan JJenkins TFong CScott A. SEXTANT ANALYSIS OF [C-11] CHOLINE PET UPTAKES IN PROSTATE OF PATIENTS UNDERGOING NEOADJUVANT DOCETAXEL CHEMOTHERAPY: VALIDATION OF SUV, SUVR, K-I AND BPND IN ASSESSING TREATMENT RESPONSE.
Internal Medicine Journal.
39-39.
2016
-
Scott ABurvenich ILee FO'Keefe GMakris DCao DGong SRigopoulos AAllan LBrechbiel MLiu ZRamsland P. Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancers.
Internal Medicine Journal.
19-19.
2016